Hester Biosciences Closes Trading Window for Q2 FY27 Results

Hester Biosciences Ltd has announced the closure of its trading window for dealing in equity shares. This closure is in accordance with SEBI (Prohibition of Insider Trading) Regulations and the company's internal code of conduct. The trading window will be shut from October 1, 2026, and will reopen 48 hours after the company's financial results for the quarter and six months ended September 30, 2026, are made public. This measure is standard practice to prevent insider trading during periods when sensitive financial information is being prepared and disseminated.